AOPs conceptually link molecular initiating events and adverse biological outcomes.
Development of AOPs requires the assessment of their weight of evidence (WoE).
This paper describes a semi-quantitative method to evaluate WoE for AOPs.
WoE criteria are based on EPA General Assessment Factors and Bradford Hill criteria.
Two illustrative case studies are shown to demonstrate the WoE assessment method.